{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.6163","meta":{"versionId":"5","lastUpdated":"2020-08-18T10:21:27.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>COVID19 SNOMED Value Set for Leukemia</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <a href=\"http://www.snomed.org/\">\n            <code>http://snomed.info/sct</code>\n          </a>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=103688009\">103688009</a>\n              </td>\n              <td>Acute myeloid leukemia with abnormal marrow eosinophils and inv(16)(p13q22) or t(16;16)(p13;q22) (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=103689001\">103689001</a>\n              </td>\n              <td>Acute myeloid leukemia, minimal differentiation (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=103690005\">103690005</a>\n              </td>\n              <td>Acute myeloid leukemia without maturation (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=103691009\">103691009</a>\n              </td>\n              <td>Acute myeloid leukemia with maturation (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=109991003\">109991003</a>\n              </td>\n              <td>Acute myelofibrosis (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=110002002\">110002002</a>\n              </td>\n              <td>Mast cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=110004001\">110004001</a>\n              </td>\n              <td>Acute promyelocytic leukemia, FAB M3 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=110005000\">110005000</a>\n              </td>\n              <td>Acute myelomonocytic leukemia, FAB M4 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=110006004\">110006004</a>\n              </td>\n              <td>Prolymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=110007008\">110007008</a>\n              </td>\n              <td>Adult T-cell leukemia/lymphoma (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=118613001\">118613001</a>\n              </td>\n              <td>Hairy cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=122881000119107\">122881000119107</a>\n              </td>\n              <td>Chronic monocytic leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=122901000119109\">122901000119109</a>\n              </td>\n              <td>Myeloid leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=122951000119108\">122951000119108</a>\n              </td>\n              <td>Lymphoid leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=122961000119105\">122961000119105</a>\n              </td>\n              <td>Chronic lymphoid leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=122981000119101\">122981000119101</a>\n              </td>\n              <td>Plasma cell leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=12301000132103\">12301000132103</a>\n              </td>\n              <td>Acute lymphoid leukemia relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=12311000132101\">12311000132101</a>\n              </td>\n              <td>Refractory acute lymphoid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=123781000119107\">123781000119107</a>\n              </td>\n              <td>Chronic leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=127225006\">127225006</a>\n              </td>\n              <td>Chronic myelomonocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=127961000119108\">127961000119108</a>\n              </td>\n              <td>Aleukemic myeloid leukemia in relapse (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128818009\">128818009</a>\n              </td>\n              <td>Acute biphenotypic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128819001\">128819001</a>\n              </td>\n              <td>T-cell large granular lymphocytic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128820007\">128820007</a>\n              </td>\n              <td>Prolymphocytic leukemia, B-cell type (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128821006\">128821006</a>\n              </td>\n              <td>Prolymphocytic leukemia, T-cell type (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128822004\">128822004</a>\n              </td>\n              <td>Precursor cell lymphoblastic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128823009\">128823009</a>\n              </td>\n              <td>Precursor B-cell lymphoblastic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128824003\">128824003</a>\n              </td>\n              <td>Precursor T-cell lymphoblastic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128825002\">128825002</a>\n              </td>\n              <td>Chronic myelogenous leukemia, BCR/ABL positive (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128826001\">128826001</a>\n              </td>\n              <td>Atypical chronic myeloid leukemia, BCR/ABL negative (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128827005\">128827005</a>\n              </td>\n              <td>Acute myeloid leukemia with multilineage dysplasia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128828000\">128828000</a>\n              </td>\n              <td>Acute myeloid leukemia, t(8;21) (q22;q22) (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128829008\">128829008</a>\n              </td>\n              <td>Acute myeloid leukemia, 11q23 abnormalities (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128830003\">128830003</a>\n              </td>\n              <td>Therapy-related acute myeloid leukemia and myelodysplastic syndrome (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128832006\">128832006</a>\n              </td>\n              <td>Juvenile myelomonocytic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128833001\">128833001</a>\n              </td>\n              <td>Aggressive natural killer-cell leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128834007\">128834007</a>\n              </td>\n              <td>Chronic neutrophilic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128922003\">128922003</a>\n              </td>\n              <td>Plasma cell leukemia, morphology (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128923008\">128923008</a>\n              </td>\n              <td>Prolymphocytic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128924002\">128924002</a>\n              </td>\n              <td>Mast cell leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128931003\">128931003</a>\n              </td>\n              <td>Leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128932005\">128932005</a>\n              </td>\n              <td>Acute leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128933000\">128933000</a>\n              </td>\n              <td>Chronic leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128934006\">128934006</a>\n              </td>\n              <td>Myeloid leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=128935007\">128935007</a>\n              </td>\n              <td>Lymphoid leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=14317002\">14317002</a>\n              </td>\n              <td>Acute myeloid leukemia, M6 type (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=17788007\">17788007</a>\n              </td>\n              <td>Acute myeloid leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188645002\">188645002</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of lymph nodes of head, face and neck (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188648000\">188648000</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of lymph nodes of axilla and upper limb (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188649008\">188649008</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of lymph nodes of inguinal region and lower limb (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188725004\">188725004</a>\n              </td>\n              <td>Lymphoid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188726003\">188726003</a>\n              </td>\n              <td>Subacute lymphoid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188728002\">188728002</a>\n              </td>\n              <td>Aleukemic lymphoid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188729005\">188729005</a>\n              </td>\n              <td>Adult T-cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188732008\">188732008</a>\n              </td>\n              <td>Myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188733003\">188733003</a>\n              </td>\n              <td>Chronic eosinophilic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188734009\">188734009</a>\n              </td>\n              <td>Chronic neutrophilic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188736006\">188736006</a>\n              </td>\n              <td>Subacute myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188737002\">188737002</a>\n              </td>\n              <td>Chloroma (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188741003\">188741003</a>\n              </td>\n              <td>Aleukemic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188744006\">188744006</a>\n              </td>\n              <td>Monocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188745007\">188745007</a>\n              </td>\n              <td>Chronic monocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188746008\">188746008</a>\n              </td>\n              <td>Subacute monocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188748009\">188748009</a>\n              </td>\n              <td>Aleukemic monocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188754005\">188754005</a>\n              </td>\n              <td>Megakaryocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188768003\">188768003</a>\n              </td>\n              <td>Myelomonocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=188770007\">188770007</a>\n              </td>\n              <td>Subacute myelomonocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=190030009\">190030009</a>\n              </td>\n              <td>Compound leukemias (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=190055003\">190055003</a>\n              </td>\n              <td>Eosinophilic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=22197008\">22197008</a>\n              </td>\n              <td>Burkitt cell leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=22331004\">22331004</a>\n              </td>\n              <td>Acute monocytic leukemia, morphology (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=24072005\">24072005</a>\n              </td>\n              <td>Acute leukemia, morphology, including blast cell OR undifferentiated leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277473004\">277473004</a>\n              </td>\n              <td>B-cell chronic lymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277474005\">277474005</a>\n              </td>\n              <td>B-cell chronic lymphocytic leukemia variant (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277545003\">277545003</a>\n              </td>\n              <td>T-cell chronic lymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277549009\">277549009</a>\n              </td>\n              <td>Chronic lymphocytic prolymphocytic leukemia syndrome (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277550009\">277550009</a>\n              </td>\n              <td>Richter's syndrome (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277551008\">277551008</a>\n              </td>\n              <td>Splenic lymphoma with villous lymphocytes (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277567002\">277567002</a>\n              </td>\n              <td>T-cell prolymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277568007\">277568007</a>\n              </td>\n              <td>Hairy cell leukemia variant (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277569004\">277569004</a>\n              </td>\n              <td>Large granular lymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277570003\">277570003</a>\n              </td>\n              <td>Lymphoma with spill (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277571004\">277571004</a>\n              </td>\n              <td>B-cell acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277572006\">277572006</a>\n              </td>\n              <td>Precursor B-cell acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277573001\">277573001</a>\n              </td>\n              <td>Common acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277574007\">277574007</a>\n              </td>\n              <td>Null cell acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277575008\">277575008</a>\n              </td>\n              <td>T-cell acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277587001\">277587001</a>\n              </td>\n              <td>Juvenile chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277589003\">277589003</a>\n              </td>\n              <td>Atypical chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277601005\">277601005</a>\n              </td>\n              <td>Acute monoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277602003\">277602003</a>\n              </td>\n              <td>Acute megakaryoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277604002\">277604002</a>\n              </td>\n              <td>Acute eosinophilic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=277619001\">277619001</a>\n              </td>\n              <td>B-cell prolymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=278189009\">278189009</a>\n              </td>\n              <td>Hypergranular promyelocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=278453007\">278453007</a>\n              </td>\n              <td>Acute biphenotypic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=285769009\">285769009</a>\n              </td>\n              <td>Acute promyelocytic leukemia - hypogranular variant (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=285839005\">285839005</a>\n              </td>\n              <td>Acute myelomonocytic leukemia - eosinophilic variant (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=28950004\">28950004</a>\n              </td>\n              <td>Acute promyelocytic leukemia, t(15;17)(q22;q11-12) (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=302855005\">302855005</a>\n              </td>\n              <td>Subacute leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=302856006\">302856006</a>\n              </td>\n              <td>Aleukemic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=307341004\">307341004</a>\n              </td>\n              <td>Atypical hairy cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=307592006\">307592006</a>\n              </td>\n              <td>Basophilic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=307617006\">307617006</a>\n              </td>\n              <td>Neutrophilic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=30962008\">30962008</a>\n              </td>\n              <td>Acute myelomonocytic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=32280000\">32280000</a>\n              </td>\n              <td>Lymphoid leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=35287006\">35287006</a>\n              </td>\n              <td>Myeloid sarcoma, morphology (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=359631009\">359631009</a>\n              </td>\n              <td>Acute myeloid leukemia, minimal differentiation, FAB M0 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=359640008\">359640008</a>\n              </td>\n              <td>Acute myeloid leukemia without maturation, FAB M1 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=359648001\">359648001</a>\n              </td>\n              <td>Acute myeloid leukemia with maturation, FAB M2 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=371012000\">371012000</a>\n              </td>\n              <td>Acute lymphoblastic leukemia, transitional pre-B-cell (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=37810007\">37810007</a>\n              </td>\n              <td>Myeloid leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=397340004\">397340004</a>\n              </td>\n              <td>Acute myeloid leukemia with recurrent genetic abnormality (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=397341000\">397341000</a>\n              </td>\n              <td>Acute myeloid leukemia with multilineage dysplasia following a myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disorder (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=397342007\">397342007</a>\n              </td>\n              <td>Acute myeloid leukemia with multilineage dysplasia without antecedent myelodysplastic syndrome (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=397343002\">397343002</a>\n              </td>\n              <td>Therapy-related acute myeloid leukemia and myelodysplastic syndrome, alkylating agent-related type (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=397344008\">397344008</a>\n              </td>\n              <td>Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=397345009\">397345009</a>\n              </td>\n              <td>Acute leukemia of ambiguous lineage (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=404139001\">404139001</a>\n              </td>\n              <td>Leukemic infiltration of skin in hairy-cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=404151004\">404151004</a>\n              </td>\n              <td>Leukemic infiltration of skin in myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=404152006\">404152006</a>\n              </td>\n              <td>Leukemic infiltration of skin in acute myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=404153001\">404153001</a>\n              </td>\n              <td>Leukemic infiltration of skin in chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=404154007\">404154007</a>\n              </td>\n              <td>Leukemic infiltration of skin in monocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=404172001\">404172001</a>\n              </td>\n              <td>Mast cell leukemia affecting skin (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413389003\">413389003</a>\n              </td>\n              <td>Accelerated phase chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413440007\">413440007</a>\n              </td>\n              <td>Acute lymphoblastic leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413441006\">413441006</a>\n              </td>\n              <td>Acute monocytic leukemia, FAB M5b (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413442004\">413442004</a>\n              </td>\n              <td>Acute monocytic/monoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413443009\">413443009</a>\n              </td>\n              <td>Acute myeloid leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413656006\">413656006</a>\n              </td>\n              <td>Blastic phase chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413836008\">413836008</a>\n              </td>\n              <td>Chronic eosinophilic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413840004\">413840004</a>\n              </td>\n              <td>Chronic lymphoid leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413841000\">413841000</a>\n              </td>\n              <td>Chronic myeloid leukemia - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413842007\">413842007</a>\n              </td>\n              <td>Chronic myeloid leukemia in lymphoid blast crisis (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413843002\">413843002</a>\n              </td>\n              <td>Chronic myeloid leukemia in myeloid blast crisis (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=413847001\">413847001</a>\n              </td>\n              <td>Chronic phase chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=415287001\">415287001</a>\n              </td>\n              <td>Relapsing chronic myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=425688002\">425688002</a>\n              </td>\n              <td>Philadelphia chromosome-positive acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=426955004\">426955004</a>\n              </td>\n              <td>Philadelphia chromosome-positive acute lymphoblastic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=430338009\">430338009</a>\n              </td>\n              <td>Smoldering chronic lymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=444911000\">444911000</a>\n              </td>\n              <td>Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=445227008\">445227008</a>\n              </td>\n              <td>Juvenile myelomonocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=445448008\">445448008</a>\n              </td>\n              <td>Acute myeloid leukemia with myelodysplasia-related changes (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=449108003\">449108003</a>\n              </td>\n              <td>Philadelphia chromosome positive chronic myelogenous leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=449386007\">449386007</a>\n              </td>\n              <td>Philadelphia chromosome negative chronic myelogenous leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450913003\">450913003</a>\n              </td>\n              <td>Mixed phenotype acute leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450914009\">450914009</a>\n              </td>\n              <td>Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450915005\">450915005</a>\n              </td>\n              <td>Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450916006\">450916006</a>\n              </td>\n              <td>Mixed phenotype acute leukemia with myeloid and B-cell lymphoid phenotypes (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450917002\">450917002</a>\n              </td>\n              <td>Mixed phenotype acute leukemia with myeloid and T-cell lymphoid phenotypes (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450920005\">450920005</a>\n              </td>\n              <td>B lymphoblastic leukemia / lymphoma - category (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450928003\">450928003</a>\n              </td>\n              <td>Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450929006\">450929006</a>\n              </td>\n              <td>Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450935006\">450935006</a>\n              </td>\n              <td>Myeloid leukemia associated with Down Syndrome (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450937003\">450937003</a>\n              </td>\n              <td>Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450949002\">450949002</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450950002\">450950002</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450951003\">450951003</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450952005\">450952005</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450953000\">450953000</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with hyperdiploidy (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450954006\">450954006</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with hypodiploidy (Hypodiploid ALL) (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450955007\">450955007</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=450956008\">450956008</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=51092000\">51092000</a>\n              </td>\n              <td>B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=52220008\">52220008</a>\n              </td>\n              <td>Acute megakaryoblastic leukemia, morphology (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=54087003\">54087003</a>\n              </td>\n              <td>Hairy cell leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=61301000119102\">61301000119102</a>\n              </td>\n              <td>Disorder of central nervous system co-occurrent and due to acute lymphoid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=63364005\">63364005</a>\n              </td>\n              <td>Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=69077002\">69077002</a>\n              </td>\n              <td>Acute basophilic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=699818003\">699818003</a>\n              </td>\n              <td>T-cell large granular lymphocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=702446006\">702446006</a>\n              </td>\n              <td>Core binding factor acute myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=703387000\">703387000</a>\n              </td>\n              <td>Acute myeloid leukemia with normal karyotype (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=703818007\">703818007</a>\n              </td>\n              <td>Acute monoblastic and monocytic leukemia (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=703819004\">703819004</a>\n              </td>\n              <td>Acute myeloid leukemia with mutation of CCAAT enhancer binding protein alpha gene (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=703820005\">703820005</a>\n              </td>\n              <td>Acute myeloid leukemia with mutated NPM1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=703821009\">703821009</a>\n              </td>\n              <td>T lymphoblastic leukemia/lymphoma (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=709471005\">709471005</a>\n              </td>\n              <td>Periodontitis co-occurrent with leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=714251006\">714251006</a>\n              </td>\n              <td>Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=721305008\">721305008</a>\n              </td>\n              <td>Acute myeloid leukemia due to recurrent genetic abnormality (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=721306009\">721306009</a>\n              </td>\n              <td>Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=721308005\">721308005</a>\n              </td>\n              <td>Acute leukemia of ambiguous lineage (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=721310007\">721310007</a>\n              </td>\n              <td>Aggressive natural killer-cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=722795004\">722795004</a>\n              </td>\n              <td>Meningeal leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=723889003\">723889003</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with t(9:22) (q34;q11.2); BCR-ABL 1 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=724644005\">724644005</a>\n              </td>\n              <td>Myeloid leukemia co-occurrent with Down syndrome (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=725390002\">725390002</a>\n              </td>\n              <td>Acute myeloid leukemia with t(8;16)(p11;p13) translocation (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=725391003\">725391003</a>\n              </td>\n              <td>Acute myeloid leukemia with t(8;16)(p11;p13) translocation (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=725437002\">725437002</a>\n              </td>\n              <td>Chronic lymphocytic leukemia genetic mutation variant (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=733598001\">733598001</a>\n              </td>\n              <td>Acute myeloid leukemia with t(6;9)(p23;q34) translocation (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=734522002\">734522002</a>\n              </td>\n              <td>Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=734524001\">734524001</a>\n              </td>\n              <td>Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=762315004\">762315004</a>\n              </td>\n              <td>Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=763309005\">763309005</a>\n              </td>\n              <td>Acute myeloid leukemia with nucleophosmin 1 somatic mutation (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=763796007\">763796007</a>\n              </td>\n              <td>Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=764855007\">764855007</a>\n              </td>\n              <td>Acute myeloid leukemia with CCAAT/enhancer binding protein alpha somatic mutation (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=764940002\">764940002</a>\n              </td>\n              <td>Inherited acute myeloid leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=766045006\">766045006</a>\n              </td>\n              <td>Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=766046007\">766046007</a>\n              </td>\n              <td>Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=766048008\">766048008</a>\n              </td>\n              <td>Acute myeloid leukemia and myelodysplastic syndrome related to radiation (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=770402000\">770402000</a>\n              </td>\n              <td>Aleukemic mast cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=773537001\">773537001</a>\n              </td>\n              <td>Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=77430005\">77430005</a>\n              </td>\n              <td>Adult T-cell leukemia/lymphoma (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=780841002\">780841002</a>\n              </td>\n              <td>Classic mast cell leukemia (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=780844005\">780844005</a>\n              </td>\n              <td>Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=783017000\">783017000</a>\n              </td>\n              <td>Acute myeloid leukemia with BCR-ABL1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=783263001\">783263001</a>\n              </td>\n              <td>Acute myeloid leukemia with mutated RUNX1 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=783744003\">783744003</a>\n              </td>\n              <td>B-lymphoblastic leukemia lymphoma BCR-ABL1-like (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=785825000\">785825000</a>\n              </td>\n              <td>B lymphoblastic leukemia lymphoma with intrachromosomal amplification of chromosome 21 (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=788740009\">788740009</a>\n              </td>\n              <td>Acute myeloid leukemia with biallelic mutation of CCAAT enhancer binding protein alpha gene (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=80570006\">80570006</a>\n              </td>\n              <td>Acute panmyelosis with myelofibrosis (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=87163000\">87163000</a>\n              </td>\n              <td>Leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=91855006\">91855006</a>\n              </td>\n              <td>Acute leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=91857003\">91857003</a>\n              </td>\n              <td>Acute lymphoid leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=91861009\">91861009</a>\n              </td>\n              <td>Acute myeloid leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=92812005\">92812005</a>\n              </td>\n              <td>Chronic leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=92814006\">92814006</a>\n              </td>\n              <td>Chronic lymphoid leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=92818009\">92818009</a>\n              </td>\n              <td>Chronic myeloid leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93143009\">93143009</a>\n              </td>\n              <td>Leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93144003\">93144003</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of intra-abdominal lymph nodes (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93145002\">93145002</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of intrapelvic lymph nodes (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93146001\">93146001</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of intrathoracic lymph nodes (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93150008\">93150008</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of lymph nodes of multiple sites (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93151007\">93151007</a>\n              </td>\n              <td>Hairy cell leukemia of spleen (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93152000\">93152000</a>\n              </td>\n              <td>Leukemic reticuloendotheliosis of extranodal AND/OR solid organ site (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=93451002\">93451002</a>\n              </td>\n              <td>Erythroleukemia, FAB M6 (disorder)</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>\n                <a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=95210003\">95210003</a>\n              </td>\n              <td>Plasma cell leukemia, disease (disorder)</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.6163","version":"20200710","name":"COVID19 SNOMED Value Set for Leukemia","status":"active","date":"2020-07-10T01:00:50-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"103688009","display":"Acute myeloid leukemia with abnormal marrow eosinophils and inv(16)(p13q22) or t(16;16)(p13;q22) (morphologic abnormality)"},{"code":"103689001","display":"Acute myeloid leukemia, minimal differentiation (morphologic abnormality)"},{"code":"103690005","display":"Acute myeloid leukemia without maturation (morphologic abnormality)"},{"code":"103691009","display":"Acute myeloid leukemia with maturation (morphologic abnormality)"},{"code":"109991003","display":"Acute myelofibrosis (disorder)"},{"code":"110002002","display":"Mast cell leukemia (disorder)"},{"code":"110004001","display":"Acute promyelocytic leukemia, FAB M3 (disorder)"},{"code":"110005000","display":"Acute myelomonocytic leukemia, FAB M4 (disorder)"},{"code":"110006004","display":"Prolymphocytic leukemia (disorder)"},{"code":"110007008","display":"Adult T-cell leukemia/lymphoma (disorder)"},{"code":"118613001","display":"Hairy cell leukemia (disorder)"},{"code":"122881000119107","display":"Chronic monocytic leukemia in relapse (disorder)"},{"code":"122901000119109","display":"Myeloid leukemia in relapse (disorder)"},{"code":"122951000119108","display":"Lymphoid leukemia in relapse (disorder)"},{"code":"122961000119105","display":"Chronic lymphoid leukemia in relapse (disorder)"},{"code":"122981000119101","display":"Plasma cell leukemia in relapse (disorder)"},{"code":"12301000132103","display":"Acute lymphoid leukemia relapse (disorder)"},{"code":"12311000132101","display":"Refractory acute lymphoid leukemia (disorder)"},{"code":"123781000119107","display":"Chronic leukemia in relapse (disorder)"},{"code":"127225006","display":"Chronic myelomonocytic leukemia (disorder)"},{"code":"127961000119108","display":"Aleukemic myeloid leukemia in relapse (disorder)"},{"code":"128818009","display":"Acute biphenotypic leukemia (morphologic abnormality)"},{"code":"128819001","display":"T-cell large granular lymphocytic leukemia (morphologic abnormality)"},{"code":"128820007","display":"Prolymphocytic leukemia, B-cell type (morphologic abnormality)"},{"code":"128821006","display":"Prolymphocytic leukemia, T-cell type (morphologic abnormality)"},{"code":"128822004","display":"Precursor cell lymphoblastic leukemia (morphologic abnormality)"},{"code":"128823009","display":"Precursor B-cell lymphoblastic leukemia (morphologic abnormality)"},{"code":"128824003","display":"Precursor T-cell lymphoblastic leukemia (morphologic abnormality)"},{"code":"128825002","display":"Chronic myelogenous leukemia, BCR/ABL positive (morphologic abnormality)"},{"code":"128826001","display":"Atypical chronic myeloid leukemia, BCR/ABL negative (morphologic abnormality)"},{"code":"128827005","display":"Acute myeloid leukemia with multilineage dysplasia (morphologic abnormality)"},{"code":"128828000","display":"Acute myeloid leukemia, t(8;21) (q22;q22) (morphologic abnormality)"},{"code":"128829008","display":"Acute myeloid leukemia, 11q23 abnormalities (morphologic abnormality)"},{"code":"128830003","display":"Therapy-related acute myeloid leukemia and myelodysplastic syndrome (morphologic abnormality)"},{"code":"128832006","display":"Juvenile myelomonocytic leukemia (morphologic abnormality)"},{"code":"128833001","display":"Aggressive natural killer-cell leukemia (morphologic abnormality)"},{"code":"128834007","display":"Chronic neutrophilic leukemia (morphologic abnormality)"},{"code":"128922003","display":"Plasma cell leukemia, morphology (morphologic abnormality)"},{"code":"128923008","display":"Prolymphocytic leukemia (morphologic abnormality)"},{"code":"128924002","display":"Mast cell leukemia (morphologic abnormality)"},{"code":"128931003","display":"Leukemia - category (morphologic abnormality)"},{"code":"128932005","display":"Acute leukemia - category (morphologic abnormality)"},{"code":"128933000","display":"Chronic leukemia - category (morphologic abnormality)"},{"code":"128934006","display":"Myeloid leukemia - category (morphologic abnormality)"},{"code":"128935007","display":"Lymphoid leukemia - category (morphologic abnormality)"},{"code":"14317002","display":"Acute myeloid leukemia, M6 type (morphologic abnormality)"},{"code":"17788007","display":"Acute myeloid leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"},{"code":"188645002","display":"Leukemic reticuloendotheliosis of lymph nodes of head, face and neck (disorder)"},{"code":"188648000","display":"Leukemic reticuloendotheliosis of lymph nodes of axilla and upper limb (disorder)"},{"code":"188649008","display":"Leukemic reticuloendotheliosis of lymph nodes of inguinal region and lower limb (disorder)"},{"code":"188725004","display":"Lymphoid leukemia (disorder)"},{"code":"188726003","display":"Subacute lymphoid leukemia (disorder)"},{"code":"188728002","display":"Aleukemic lymphoid leukemia (disorder)"},{"code":"188729005","display":"Adult T-cell leukemia (disorder)"},{"code":"188732008","display":"Myeloid leukemia (disorder)"},{"code":"188733003","display":"Chronic eosinophilic leukemia (disorder)"},{"code":"188734009","display":"Chronic neutrophilic leukemia (disorder)"},{"code":"188736006","display":"Subacute myeloid leukemia (disorder)"},{"code":"188737002","display":"Chloroma (disorder)"},{"code":"188741003","display":"Aleukemic myeloid leukemia (disorder)"},{"code":"188744006","display":"Monocytic leukemia (disorder)"},{"code":"188745007","display":"Chronic monocytic leukemia (disorder)"},{"code":"188746008","display":"Subacute monocytic leukemia (disorder)"},{"code":"188748009","display":"Aleukemic monocytic leukemia (disorder)"},{"code":"188754005","display":"Megakaryocytic leukemia (disorder)"},{"code":"188768003","display":"Myelomonocytic leukemia (disorder)"},{"code":"188770007","display":"Subacute myelomonocytic leukemia (disorder)"},{"code":"190030009","display":"Compound leukemias (disorder)"},{"code":"190055003","display":"Eosinophilic leukemia (morphologic abnormality)"},{"code":"22197008","display":"Burkitt cell leukemia (morphologic abnormality)"},{"code":"22331004","display":"Acute monocytic leukemia, morphology (morphologic abnormality)"},{"code":"24072005","display":"Acute leukemia, morphology, including blast cell OR undifferentiated leukemia (morphologic abnormality)"},{"code":"277473004","display":"B-cell chronic lymphocytic leukemia (disorder)"},{"code":"277474005","display":"B-cell chronic lymphocytic leukemia variant (disorder)"},{"code":"277545003","display":"T-cell chronic lymphocytic leukemia (disorder)"},{"code":"277549009","display":"Chronic lymphocytic prolymphocytic leukemia syndrome (disorder)"},{"code":"277550009","display":"Richter's syndrome (disorder)"},{"code":"277551008","display":"Splenic lymphoma with villous lymphocytes (disorder)"},{"code":"277567002","display":"T-cell prolymphocytic leukemia (disorder)"},{"code":"277568007","display":"Hairy cell leukemia variant (disorder)"},{"code":"277569004","display":"Large granular lymphocytic leukemia (disorder)"},{"code":"277570003","display":"Lymphoma with spill (disorder)"},{"code":"277571004","display":"B-cell acute lymphoblastic leukemia (disorder)"},{"code":"277572006","display":"Precursor B-cell acute lymphoblastic leukemia (disorder)"},{"code":"277573001","display":"Common acute lymphoblastic leukemia (disorder)"},{"code":"277574007","display":"Null cell acute lymphoblastic leukemia (disorder)"},{"code":"277575008","display":"T-cell acute lymphoblastic leukemia (disorder)"},{"code":"277587001","display":"Juvenile chronic myeloid leukemia (disorder)"},{"code":"277589003","display":"Atypical chronic myeloid leukemia (disorder)"},{"code":"277601005","display":"Acute monoblastic leukemia (disorder)"},{"code":"277602003","display":"Acute megakaryoblastic leukemia (disorder)"},{"code":"277604002","display":"Acute eosinophilic leukemia (disorder)"},{"code":"277619001","display":"B-cell prolymphocytic leukemia (disorder)"},{"code":"278189009","display":"Hypergranular promyelocytic leukemia (disorder)"},{"code":"278453007","display":"Acute biphenotypic leukemia (disorder)"},{"code":"285769009","display":"Acute promyelocytic leukemia - hypogranular variant (disorder)"},{"code":"285839005","display":"Acute myelomonocytic leukemia - eosinophilic variant (disorder)"},{"code":"28950004","display":"Acute promyelocytic leukemia, t(15;17)(q22;q11-12) (morphologic abnormality)"},{"code":"302855005","display":"Subacute leukemia (disorder)"},{"code":"302856006","display":"Aleukemic leukemia (disorder)"},{"code":"307341004","display":"Atypical hairy cell leukemia (disorder)"},{"code":"307592006","display":"Basophilic leukemia (disorder)"},{"code":"307617006","display":"Neutrophilic leukemia (disorder)"},{"code":"30962008","display":"Acute myelomonocytic leukemia (morphologic abnormality)"},{"code":"32280000","display":"Lymphoid leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"},{"code":"35287006","display":"Myeloid sarcoma, morphology (morphologic abnormality)"},{"code":"359631009","display":"Acute myeloid leukemia, minimal differentiation, FAB M0 (disorder)"},{"code":"359640008","display":"Acute myeloid leukemia without maturation, FAB M1 (disorder)"},{"code":"359648001","display":"Acute myeloid leukemia with maturation, FAB M2 (disorder)"},{"code":"371012000","display":"Acute lymphoblastic leukemia, transitional pre-B-cell (disorder)"},{"code":"37810007","display":"Myeloid leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"},{"code":"397340004","display":"Acute myeloid leukemia with recurrent genetic abnormality (morphologic abnormality)"},{"code":"397341000","display":"Acute myeloid leukemia with multilineage dysplasia following a myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disorder (morphologic abnormality)"},{"code":"397342007","display":"Acute myeloid leukemia with multilineage dysplasia without antecedent myelodysplastic syndrome (morphologic abnormality)"},{"code":"397343002","display":"Therapy-related acute myeloid leukemia and myelodysplastic syndrome, alkylating agent-related type (morphologic abnormality)"},{"code":"397344008","display":"Therapy-related acute myeloid leukemia and myelodysplastic syndrome, topoisomerase type II inhibitor-related type (morphologic abnormality)"},{"code":"397345009","display":"Acute leukemia of ambiguous lineage (morphologic abnormality)"},{"code":"404139001","display":"Leukemic infiltration of skin in hairy-cell leukemia (disorder)"},{"code":"404151004","display":"Leukemic infiltration of skin in myeloid leukemia (disorder)"},{"code":"404152006","display":"Leukemic infiltration of skin in acute myeloid leukemia (disorder)"},{"code":"404153001","display":"Leukemic infiltration of skin in chronic myeloid leukemia (disorder)"},{"code":"404154007","display":"Leukemic infiltration of skin in monocytic leukemia (disorder)"},{"code":"404172001","display":"Mast cell leukemia affecting skin (disorder)"},{"code":"413389003","display":"Accelerated phase chronic myeloid leukemia (disorder)"},{"code":"413440007","display":"Acute lymphoblastic leukemia - category (morphologic abnormality)"},{"code":"413441006","display":"Acute monocytic leukemia, FAB M5b (disorder)"},{"code":"413442004","display":"Acute monocytic/monoblastic leukemia (disorder)"},{"code":"413443009","display":"Acute myeloid leukemia - category (morphologic abnormality)"},{"code":"413656006","display":"Blastic phase chronic myeloid leukemia (disorder)"},{"code":"413836008","display":"Chronic eosinophilic leukemia (morphologic abnormality)"},{"code":"413840004","display":"Chronic lymphoid leukemia - category (morphologic abnormality)"},{"code":"413841000","display":"Chronic myeloid leukemia - category (morphologic abnormality)"},{"code":"413842007","display":"Chronic myeloid leukemia in lymphoid blast crisis (disorder)"},{"code":"413843002","display":"Chronic myeloid leukemia in myeloid blast crisis (disorder)"},{"code":"413847001","display":"Chronic phase chronic myeloid leukemia (disorder)"},{"code":"415287001","display":"Relapsing chronic myeloid leukemia (disorder)"},{"code":"425688002","display":"Philadelphia chromosome-positive acute lymphoblastic leukemia (disorder)"},{"code":"426955004","display":"Philadelphia chromosome-positive acute lymphoblastic leukemia (morphologic abnormality)"},{"code":"430338009","display":"Smoldering chronic lymphocytic leukemia (disorder)"},{"code":"444911000","display":"Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL (disorder)"},{"code":"445227008","display":"Juvenile myelomonocytic leukemia (disorder)"},{"code":"445448008","display":"Acute myeloid leukemia with myelodysplasia-related changes (disorder)"},{"code":"449108003","display":"Philadelphia chromosome positive chronic myelogenous leukemia (disorder)"},{"code":"449386007","display":"Philadelphia chromosome negative chronic myelogenous leukemia (disorder)"},{"code":"450913003","display":"Mixed phenotype acute leukemia (morphologic abnormality)"},{"code":"450914009","display":"Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)"},{"code":"450915005","display":"Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged (morphologic abnormality)"},{"code":"450916006","display":"Mixed phenotype acute leukemia with myeloid and B-cell lymphoid phenotypes (morphologic abnormality)"},{"code":"450917002","display":"Mixed phenotype acute leukemia with myeloid and T-cell lymphoid phenotypes (morphologic abnormality)"},{"code":"450920005","display":"B lymphoblastic leukemia / lymphoma - category (morphologic abnormality)"},{"code":"450928003","display":"Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 (morphologic abnormality)"},{"code":"450929006","display":"Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (morphologic abnormality)"},{"code":"450935006","display":"Myeloid leukemia associated with Down Syndrome (morphologic abnormality)"},{"code":"450937003","display":"Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 (morphologic abnormality)"},{"code":"450949002","display":"B lymphoblastic leukemia lymphoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"},{"code":"450950002","display":"B lymphoblastic leukemia lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)"},{"code":"450951003","display":"B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged (morphologic abnormality)"},{"code":"450952005","display":"B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (morphologic abnormality)"},{"code":"450953000","display":"B lymphoblastic leukemia lymphoma with hyperdiploidy (morphologic abnormality)"},{"code":"450954006","display":"B lymphoblastic leukemia lymphoma with hypodiploidy (Hypodiploid ALL) (morphologic abnormality)"},{"code":"450955007","display":"B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH (morphologic abnormality)"},{"code":"450956008","display":"B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) (morphologic abnormality)"},{"code":"51092000","display":"B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (morphologic abnormality)"},{"code":"52220008","display":"Acute megakaryoblastic leukemia, morphology (morphologic abnormality)"},{"code":"54087003","display":"Hairy cell leukemia (morphologic abnormality)"},{"code":"61301000119102","display":"Disorder of central nervous system co-occurrent and due to acute lymphoid leukemia (disorder)"},{"code":"63364005","display":"Chronic myelogenous leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"},{"code":"69077002","display":"Acute basophilic leukemia (morphologic abnormality)"},{"code":"699818003","display":"T-cell large granular lymphocytic leukemia (disorder)"},{"code":"702446006","display":"Core binding factor acute myeloid leukemia (disorder)"},{"code":"703387000","display":"Acute myeloid leukemia with normal karyotype (disorder)"},{"code":"703818007","display":"Acute monoblastic and monocytic leukemia (morphologic abnormality)"},{"code":"703819004","display":"Acute myeloid leukemia with mutation of CCAAT enhancer binding protein alpha gene (morphologic abnormality)"},{"code":"703820005","display":"Acute myeloid leukemia with mutated NPM1 (morphologic abnormality)"},{"code":"703821009","display":"T lymphoblastic leukemia/lymphoma (morphologic abnormality)"},{"code":"709471005","display":"Periodontitis co-occurrent with leukemia (disorder)"},{"code":"714251006","display":"Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (disorder)"},{"code":"721305008","display":"Acute myeloid leukemia due to recurrent genetic abnormality (disorder)"},{"code":"721306009","display":"Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder)"},{"code":"721308005","display":"Acute leukemia of ambiguous lineage (disorder)"},{"code":"721310007","display":"Aggressive natural killer-cell leukemia (disorder)"},{"code":"722795004","display":"Meningeal leukemia (disorder)"},{"code":"723889003","display":"B lymphoblastic leukemia lymphoma with t(9:22) (q34;q11.2); BCR-ABL 1 (disorder)"},{"code":"724644005","display":"Myeloid leukemia co-occurrent with Down syndrome (disorder)"},{"code":"725390002","display":"Acute myeloid leukemia with t(8;16)(p11;p13) translocation (disorder)"},{"code":"725391003","display":"Acute myeloid leukemia with t(8;16)(p11;p13) translocation (morphologic abnormality)"},{"code":"725437002","display":"Chronic lymphocytic leukemia genetic mutation variant (disorder)"},{"code":"733598001","display":"Acute myeloid leukemia with t(6;9)(p23;q34) translocation (disorder)"},{"code":"734522002","display":"Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation (disorder)"},{"code":"734524001","display":"Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation (morphologic abnormality)"},{"code":"762315004","display":"Therapy related acute myeloid leukemia due to and following administration of antineoplastic agent (disorder)"},{"code":"763309005","display":"Acute myeloid leukemia with nucleophosmin 1 somatic mutation (disorder)"},{"code":"763796007","display":"Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13) (disorder)"},{"code":"764855007","display":"Acute myeloid leukemia with CCAAT/enhancer binding protein alpha somatic mutation (disorder)"},{"code":"764940002","display":"Inherited acute myeloid leukemia (disorder)"},{"code":"766045006","display":"Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder)"},{"code":"766046007","display":"Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder)"},{"code":"766048008","display":"Acute myeloid leukemia and myelodysplastic syndrome related to radiation (disorder)"},{"code":"770402000","display":"Aleukemic mast cell leukemia (disorder)"},{"code":"773537001","display":"Differentiation syndrome due to and following chemotherapy co-occurrent with acute promyelocytic leukemia (disorder)"},{"code":"77430005","display":"Adult T-cell leukemia/lymphoma (morphologic abnormality)"},{"code":"780841002","display":"Classic mast cell leukemia (disorder)"},{"code":"780844005","display":"Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (disorder)"},{"code":"783017000","display":"Acute myeloid leukemia with BCR-ABL1 (morphologic abnormality)"},{"code":"783263001","display":"Acute myeloid leukemia with mutated RUNX1 (morphologic abnormality)"},{"code":"783744003","display":"B-lymphoblastic leukemia lymphoma BCR-ABL1-like (morphologic abnormality)"},{"code":"785825000","display":"B lymphoblastic leukemia lymphoma with intrachromosomal amplification of chromosome 21 (morphologic abnormality)"},{"code":"788740009","display":"Acute myeloid leukemia with biallelic mutation of CCAAT enhancer binding protein alpha gene (morphologic abnormality)"},{"code":"80570006","display":"Acute panmyelosis with myelofibrosis (morphologic abnormality)"},{"code":"87163000","display":"Leukemia, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"},{"code":"91855006","display":"Acute leukemia, disease (disorder)"},{"code":"91857003","display":"Acute lymphoid leukemia, disease (disorder)"},{"code":"91861009","display":"Acute myeloid leukemia, disease (disorder)"},{"code":"92812005","display":"Chronic leukemia, disease (disorder)"},{"code":"92814006","display":"Chronic lymphoid leukemia, disease (disorder)"},{"code":"92818009","display":"Chronic myeloid leukemia, disease (disorder)"},{"code":"93143009","display":"Leukemia, disease (disorder)"},{"code":"93144003","display":"Leukemic reticuloendotheliosis of intra-abdominal lymph nodes (disorder)"},{"code":"93145002","display":"Leukemic reticuloendotheliosis of intrapelvic lymph nodes (disorder)"},{"code":"93146001","display":"Leukemic reticuloendotheliosis of intrathoracic lymph nodes (disorder)"},{"code":"93150008","display":"Leukemic reticuloendotheliosis of lymph nodes of multiple sites (disorder)"},{"code":"93151007","display":"Hairy cell leukemia of spleen (disorder)"},{"code":"93152000","display":"Leukemic reticuloendotheliosis of extranodal AND/OR solid organ site (disorder)"},{"code":"93451002","display":"Erythroleukemia, FAB M6 (disorder)"},{"code":"95210003","display":"Plasma cell leukemia, disease (disorder)"}]}]}}